Cargando…
Treg activation defect in type 1 diabetes: correction with TNFR2 agonism
Activated T-regulatory cells (aTregs) prevent or halt various forms of autoimmunity. We show that type 1 diabetics (T1D) have a Treg activation defect through an increase in resting Tregs (rTregs, CD4(+)CD25(+)Foxp3(+)CD45RA) and decrease in aTregs (CD4(+)CD25(+)Foxp3(+)CD45RO) (n= 55 T1D, n=45 cont...
Autores principales: | Okubo, Yoshiaki, Torrey, Heather, Butterworth, John, Zheng, Hui, Faustman, Denise L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4735064/ https://www.ncbi.nlm.nih.gov/pubmed/26900470 http://dx.doi.org/10.1038/cti.2015.43 |
Ejemplares similares
-
Strategic internal covalent cross-linking of TNF produces a stable TNF trimer with improved TNFR2 signaling
por: Ban, Liqin, et al.
Publicado: (2015) -
Targeted killing of TNFR2-expressing tumor cells and T(regs) by TNFR2 antagonistic antibodies in advanced Sézary syndrome
por: Torrey, H, et al.
Publicado: (2018) -
The Roles of TNFR2 Signaling in Cancer Cells and the Tumor Microenvironment and the Potency of TNFR2 Targeted Therapy
por: Takahashi, Hiroyuki, et al.
Publicado: (2022) -
TNFR2: The new Treg switch?
por: Cohen, José L., et al.
Publicado: (2017) -
Chronic Inflammation Increases the Sensitivity of Mouse Treg for TNFR2 Costimulation
por: Schmid, Tobias, et al.
Publicado: (2017)